Law ❯ Regulatory Affairs

FDA Regulations

Drug Approval Process Drug Approval Risk Evaluation and Mitigation Strategy

GOP Senators Move to Curb Mifepristone After FDA Clears Second Generic

Republican senators seek to halt distribution despite the FDA’s limited discretion to approve bioequivalent generics.

Democratic-Led States Petition FDA to Remove Mifepristone Restrictions